Investors

People are different and so is their cancer, patients should be treated individually.

New The power of precision, For Every Oncologist, Today

At 2cureX, we’re pioneers of 3D microtumors in cancer therapy, focused on improving the outcomes of cancer treatment

Product launch

2cureX launches IndiTreat^® for metastasised colon cancer, the world’s first CE validated IVD based on microtumors

Directed Issue 2020

Directed Issue 2020

Company presentation

Please click here to download our Company presentation

Structure of Directed Issue including warrants to current shareholders

Please click here to download structure of Directed Issue and warrants

Upcoming events

January 21, 2021

Fight Cancer 2021, Redeye Event, Stockholm

Click here for more information

February 10, 2021

VATOR SWISS NORDIC BIO 2021 – The Annual Nordic Healthcare Investor Summit in Zürich

February 25, 2021

2cureX Year-End Report 2020

View previous reports